Sodium Valproate Valproic Acid Tablet Franchise in Ahmedabad

Valproic Acid 145mg Tablet Supplier in Mumbai

Antiepileptic Tablet Distributor in Delhi

Neurology Tablet Manufacturer in Bangalore

Seizure Control Tablet Stockist in Hyderabad
Sodium Valproate Valproic Acid Tablet Exporter in Chandigarh

Home/Products /valpotime-cr-500-sodium-valproate-333mg-valporic-acid-145mg-tablet

About the Product

Description


Sodium Valproate 333mg + Valproic Acid 145mg tablet is an extended-release antiepileptic formulation used for the effective management of seizure disorders and epilepsy, providing prolonged therapeutic coverage.

It works by stabilizing neuronal electrical activity and enhancing GABA-mediated inhibitory neurotransmission, reducing seizure frequency and controlling abnormal nerve excitability.

This tablet is commonly prescribed for generalized and partial seizures, bipolar disorder, and migraine prevention, offering comprehensive support for neurological conditions.

With proven clinical efficacy, extended-release convenience, and strong prescription acceptance, this formulation strengthens a neurology-focused product portfolio and ensures consistent therapeutic demand.

Common side effects may include nausea, vomiting, dizziness, tremors, weight gain, or mild gastrointestinal discomfort. Rarely, liver dysfunction, pancreatitis, or thrombocytopenia may occur; regular monitoring is recommended during prolonged therapy.

Valpotime CR 500 Tablet is indicated for the management of epilepsy, including generalized and partial seizures, bipolar disorder, and migraine prophylaxis, as prescribed by a healthcare professional.

For oral use only. Use strictly under medical supervision. Do not discontinue treatment abruptly. Inform your doctor about any liver, kidney, or metabolic disorders prior to use.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions